Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Alamar Biosciences, Inc.NASDAQ: ALMR

Gross Profit · Q2 FY2026 · quarter ended Jun 2026

Gross profit of $17.72M in Q2 FY2026

Q2 FY2026 gross profit was $17.72M.

Context

  • Gross profit amounted to 56.2% of revenue in FY2025.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$17.72M+22.6% QoQ
Last fiscal yearDec 2025
$41.71M— YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
41.71M USD
Year-over-year change
—

Gross Profit vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 gross profit of $41.71M is the 5th highest of the 9 companies compared; the peer median is $50.5M.
  • Gross profit amounts to 56.2% of revenue for ALMR, versus a peer median of 48.3%.
ALMR Competitors Peer median
Gross Profit for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TECHBio-Techne CorporationLTM Sep 2026$807.58M +1.5%+1.3%65.8%
TXG10x Genomics, Inc.LTM Sep 2026$444.65M +0.6%+3.9%71.9%
TWSTTwist Bioscience CorporationLTM Sep 2026$240.8M +26.1%+39.0%52.4%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$59.34M +140.9%+1.1%37.1%
ALMRAlamar Biosciences, Inc.FY2025$41.71M ——56.2%
LABStandard BioTools Inc.LTM Mar 2026$41.66M -37.4%+4.7%48.3%
SEERSeer, Inc.LTM Mar 2026$7.26M +61.1%+70.5%48.3%
QSIQuantum-Si incorporatedLTM Mar 2026$741K -59.2%—40.0%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026-$6.32M +43.5%——
Peer median (excluding ALMR) $50.5M+13.8%+4.3%48.3%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.